Testing a safe dengue infection in immune Thai volunteers
Part of Infections clinical trials.
This study tests a controlled dengue infection in volunteers who already have immunity to some dengue types. It aims to see how safe it is and how the immune system responds, which could help develop better vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 40 years old, weigh at least 50 kg, and have completed high school.
- You must have had a dengue infection in the past (confirmed by a blood test) but never dengue type 2.
- You must not have donated blood in the last 3 months.
- If you are a woman who can become pregnant, you must be willing to use contraception or abstain from sex during the study.
- You must be able to read and sign a consent form in Thai.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This early-stage trial tests a new dengue vaccine in healthy adults. Participants will receive the vaccine and later be exposed to a weakened dengue virus to see if the vaccine protects them, while being closely monitored for safety and immune response.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
Hear when a new Safety Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.